Business
ASX 200 investors underexposed to this potential ‘great news event’ – Motley Fool Australia
If an effective vaccine against the coronavirus were uncovered this week, many ASX 200 investors would be poorly positioned to benefit.
The silver bullet to slay the coronavirus and return life to normal remains elusive. But that doesn’t mean it might not be here sooner than most S&P/ASX 200 Index (ASX: XJO) investors are pricing in.
The world’s top institutions and brightest minds are working around the clock, after all, with record amounts of private and government funding pouring in.
However, recent setbacks with some leading vaccine trials, alongside announcements that any new vaccines may only prove 50–60% effective, …
-
General10 hours agoMildura man given 28 years to pay $73,000 in unpaid fines and tolls
-
General12 hours agoAustralia’s race to rewire the country amid a global transmission boom is not unique
-
Noosa News23 hours agoSunshine Coast Airport receives green light for major upgrade opening doors to growth jobs and tourism across the region
-
General23 hours agoNZ government’s puberty blockers move attracts strong reactions